History
of transfusion and autotransfusion
L.TEFA[1], Å. ARNAOUTOGLOU[1], G. DROSOS[2], T. XENAKIS[3], G.
PAPADOPOULOS[1]
[1]Anesthesiology and Postoperative Intensive Care Clinic
[2]Cardiac Surgery Clinic
[3]Orthopaedic Surgery ClinicMailing address:
ABSTRACT
The
development of blood transfusion, the discovery of blood types and
of anticoagulant agents for its storage is described. In parallel,
the development of autologous transfusion is presented.
Key words: History, transfusion, blood.
INTRODUCTION
The relationship between life and blood has been puzzling humanity
since the old days, as it is shown in New Testament as well. Since
ancient times there have already been many references with mythological
character.
According to mythology, Medea made Jason’s father, Aesona, revive,
by cutting a vein from his neck, so the old blood would go away and
she replaced it with juice form herbs and birds’ entrails, so his
body and mind would become younger.
Also it was believed that someone who was weak could gain strength
by having a bath with blood or drinking blood from someone who was
stronger. Plenius and Celcius refer to the Romans’ custom to drink
fencers’ blood in the arena[10,23].
On the other hand, ancient Egyptians probably knew about blood transfusion.
In ancient Egyptian papyri the practice of transfusion is referred,
which is confirmed in Erophillus’s anatomy monograph[10,23].
The anatomical knowledge of ancient Greeks for blood circulation was
very limited. They believed that blood was just flowing through peripheral
veins and an amount of blood was running through the pores of interventricular
septum to mix with the "spirit" and enriched with air to
supply the brain[14]. Galenus, a Greek doctor, believed that the basic
elements phlegm, blood, yellow and black gall were responsible for
health and disease. These opinions had an obvious effect on medicine’s
principles for almost 20 centuries. So, in case of severe disease
exsanguination was applied for removing bad blood, as recommended
by Galenus. There is evidence that George Washington’s death was due
to hemorrhage which was induced by the doctors for therapeutic reasons.[23]
THE FIRST TRANSFUSIONS
The experiments for blood transfusion took place in sequential steps.
Initially with transfusions from one animal to another and then with
transfusions from animal to human.[14] The first transfusion from
human to human is reported that it was held to Pontiff Inocentius
VIIÉ in 149223. It is reported that he was transfused with blood from
3 boys, whose lives were sacrificed to no avail. According to Pasquale
Villari’s testimony, Pontiff had a stroke and he was in such deep
coma, that sometimes it was thought that he was dead. A Jewish doctor
with the help of a device which had been tested only on animals, transfused
Pontiff’s blood directly into a boy’s veins, while the boy’s blood
was being transfused to the Pontiff. For direct transfusion thin tubes
made of silk were used[23]. The experiment was repeated three times
and although the lives of the three young boys were lost it had no
result for the Pontiff’s salvation. It is speculated that the 3 boys
lost their lives not only as a result of the transfusion, but also
as a result of venous air emboli during the vein puncture. Jewish
doctor’s fate who was in charge is unknown.
The announcement by William Harvey, who describes the blood circulation
in a monograph with title «Exercitatio anatomica de moto cordis et
sanguinis in animalibus» is an important milestone in the history
of transfusion[14,23]. William Harvey himself had infused water in
the circulation of a dead man, but there is no evidence that he thought
about the possibility of blood transfusion.
The first man who performed a transfusion from animal to animal successfully
was Richard Lower[14]. These experiments were contacted on dogs in
1665 in Oxford, while the next two years transfusions from animal
to human were performed. At the same time (1667), Jean-Baptiste Denis
in Paris, reported successful transfusions from sheep to human. Dennis
was a theologian and he studied medicine at Montpellier. His first
patient was Arthur Coga, a student at the University of Cambridge,
who had been injured on his head and Dennis transfused him blood from
a sheep on 23rd of November. The patient presented a persisting fever
and confusion and for that reason he had undergone "20 therapeutic
exsanguinations". The patient survived after a second transfusion
as well on 12th of December and finally he recovered completely. Dennis
in an article who published reports that the indication for the transfusion
was not blood loss, but " mental symptoms" . He believed,
influenced by Galenus theory, that the transfusion from a quiet animal
to a worried and suffering soul could have a calm effect. However,
other patients were not so lucky, as a result transfusion to be in
disfavor and no other progress be made in the following years. It
is referred that the first reaction to transfusion is the case of
Antoine Manroy, a 34 year old man, who died and Denis was accused
for this[14.23].
At the same time parallel tries were made in Germany, when J.D. Mayor
performed his first transfusion to his teacher, Jochan Michaelis,
professor in Medical School at the University of Leibzig, who suffered
from paralysis[23].
In 1678, Paris Medical Association banned officially transfusions
from animal to human, because of adverse reactions, many of which
caused death[14].
In spite of all that, some years later, in 1714, Nuck, in his book
«Operations et Experinenta Chirurgica», refers to the importance of
transfusions and states that they should not be banned, because they
are useful in heavy hemorrhages[14]. Doen reports that 6 out of 9
transfusions that he performed were successful. For the transfusions
he was using syringe by bronze. One could wonder how transfusions
were performed without the appropriate information about the ABO blood
group system. Off-hand calculations show that 64% could be compatible,
and so Doen’s results are confirmed[23].
The first transfusion from a human to another aiming at resuscitation
was performed in 1818 by James Blundell1. Blundell was a gynecologist
at the Guy’s and St. Thomas Hospital in London. By his experiments
on dogs with hypovolemic shock he found that death from this cause
could be avoided with blood transfusion from dogs. The results were
not the same when human blood was infused to dogs. He found, also,
that venous blood had the same efficiency with arterial in animals’
resuscitation. He concluded that only human blood should be administered
to humans and this way he managed successfully women who had postpartum
hemorrhage. In 1840, Blundell and Lane present the first successful
whole blood transfusion for hemophilia therapy[14].
THE DISCOVERY OF BLOOD TYPES
It is remarkable that blood transfusion was successful, even though
blood types were unknown. There had already been references by Landois
(1875) that mixing blood cells from one animal with blood serum from
other species could lead to lysis in two minutes. Being aware of past
references, Karl Landsteiner from Vienna performed some experiments
and proved that a person’s serum could be agglutinated with the red
cells of another. He published his results in 1901, believing that
it is about a phenomenon with immunologic cause and he announced that
there are 3 blood groups A, B, C or Ï[17]. One year later the fourth
blood group was discovered, blood group AB, by De Castello and Sturli7.
However, the first one who refers to the need for crossmatching and
the definition of blood type was Ludwig Hectoen from Chicago(1907)[23].
The same year, Ottenberg describes that blood groups are inherited
by Mendel’s laws and he recognizes that blood group O is the universal
donor. The first one was not widely accepted, till the description
of blood groups inheritance by Bernstein in 1924[19].
The relative blood group distribution among races was studied by two
German researchers during the first World War[13]. Unfortunately,
these evidence was counterfeited during Nazism in Germany and used
for racist purposes. So, blood group B was attributed to Slavic and
Jewish race, while blood group Á to persons of "arian" race.
Positive characteristics, like intelligence etc to these persons.
This theory was accepted during World War II and German army accepted
blood only from ascertained donors from "arian" race. In
parallel, USA Red Cross was gathering blood only from the same race,
however it had been accepted that donors’ blood from black race could
be used for albumin production. The blood segregation according to
the race continued to be in due in some states of America till the
end of 1960. By the end of 1950 a law passed in Louisiana which forbade
doctors to administer blood from a black donor to a white patient
without his consent[18].
The first evidence for Rhesus antibodies was given by Levine, Landsteiner’s
student, but without being given a name to the new system[16]. The
name Rhesus positive is attributed to Landsteiner and Wiener (1940),
who conducted experiments on animals following Levine’s observations[16].
Other studies followed which led to the discovery of new antigens,
besides others, and to the discovery of Coombs test (1945)[4].
Kell system was recognized by Coombs himself, in 1946, after the case
of a newborn with hemolytic syndrome, which could not be explained
with Rhesus compatibility between the mother and the child[5].
THE NEED FOR AN ANTICOAGULANT FACTOR
In 19th century it had already been obvious that for fresh blood
transfusion the natural obstacle of quick coagulation should be overcome.
For this reason a surgical technique was developed by Alexis Carrel,
a French angiosurgeon, which allowed the transfusion of large amount
of blood. This was based on the temporary anastomosis of a donor’s
artery with an acceptor’s vein[3]. So, in March 1908 he used this
technique to transfuse blood to a newborn girl with her father’s blood.
For this purpose, he anastomosed the father’s left radial artery with
the newborn’s leg vein, whose condition was deteriorating dramatically.
After the transfusion the pale and motionless newborn, started crying
and gained normal color[3]. In recognition to Carrel’s work, Nobel
Prize for Medicine was attributed to him in 1912 and this technique
was widely accepted by the surgeons of those days.
Very soon though the need for a stable, but non toxic , anticoagulant
was conceived which added to the collected blood would allow its long
term storage. Already in 1868, Braxton Hicks, an English Obstetrician,
had used a phosphorus sodium solution, which proved to be toxic[12].
Some years later, in 1915, Richard Lewinsohn introduced as an anticoagulant
factor the sodium citrate in 1% solution[20]. Initially, sodium citrate
was not used for long term storage of collected blood. Experimental
studies on animals by Rous and Turner, in 1916, showed that with the
addition of glucose in sodium citrate solution blood could be stored
for two weeks[27]. In 1955 Lewinsohn was honored with Landsteiner
prize of the American organization of blood banks for the use of the
first sodium citrate solution. In 1961, after many clinical trials,
CPD solution ( citrate-phosphate-dextrose) is consolidated as an anticoagulant
by Gibson for blood preservation up to 28 days[23]. In 1967, the role
of DPG was discovered (diphosphoglycerase) by Chantin, Curnish and
Benesches, whilst with Nakaos’s work it seems that the addition of
adenine alters the conservation of ATP[23]. By 1950 the discovery
of plastic content had already been preceded by Carl Walter[14,23].
However, the problems continued to exist. There were referred fever
reactions by 10% percent of patients who received transfusions. The
problem was solved by Florence Seiber, who discovered the amount of
bacteria in ìg which were left after sterilization, and which today
we call endotoxins and are in the majority Gram negative bacilli[23].
For this discovery she was honored by the American organization of
blood banks of John Elliott Memorial in 1962.
And while the first world congress for blood transfusion had already
taken place in Rome in 1935, wars were a good motive for the developments
of blood transfusion. It had been preceded the discovery by Edwin
Cohn of the method of plasma proteins fractionation, which is still
in use today. So, human albumin and plasma were the main saving fluids
which were used for the management of shock in World War II.
An important milestone in the history of transfusion is the use of
erythropoietin, as well as the autologous transfusion and the introduction
of autotransfusion’s devices intraoperatively.
THE HISTORY OF AUTOTRANSFUSION
The first tries of autologous transfusion with reinfusion of washed
blood are performed with the purpose of surgical and obstetrical patients’
resuscitation. The first reference of blood saving is indexed in the
American bibliography in 1917[21]. Till the year 1936, 277 cases of
autologous transfusions had been presented in bibliography[6,9,11,26].
From 1931 till the beginning of 1970, there have been published sporadic
references for the use of technique on patients with hemothorax[2].
However, this technique was used only as a saving measure for a patient’s
life therefore, little was known about the quality of the product
which was being reinfused. In 1966 Symbas having considered a series
of laboratory and clinical studies compiled an autotransfusion protocol
with non elaborated blood for the therapy of patients with acute hemothorax
and it was applied to more than 400 patients between 1966 and 1978[25].
The first reports regarding to the production of devices for intraoperative
collection and autologous blood retransfusion were presented in 1966[8].
In 1969, the researchers referred to the use of a centrifuge device
with continuous flow which had the potential to separate and concentrate
red blood cells and which applied to operations of transurethral prostatectomy[28].
The first commercially available autotransfusion device was made in
Bentley laboratories and consisted of one use blood collection device
and a De Bakey type non shygmic pump. The first clinical trials were
contacted in Vietnam and were announced in 1970[15]. The first article
relating to anesthesiology appeared in 1975 with a detailed description
of the experience on 71 patients, who received a mean volume of 4000
ml autotransfused blood[24]. A systemic anticoagulant therapy was
not used, but the reservoir was full of crystalloids which contained
3 IU heparin/ml. According to the writers, the device was safe and
efficient for patients with blind and perforans thoracic and abdominal
trauma, ruptured ectopic pregnancy, as well as for patients who were
subjected to many elective and emergency intrabdominal operations.
Although the device was equipped with air detection system, air embolus
was reported as a result of wrong handling and withdrew from the market.
The great progress was made in 1974 when Haemonetics Corporation introduced
Cell Saver, a system which washes and concentrates red blood cells
before their administration. Two years later, the experience with
this device is announced[22]. Since then a great number of devices
for intraoperative and post operative autologous transfusion has been
released for clinical practice.
REFERENCES
1. Blundell J. Observations on transfusion of blood by Dr Blundell
with a description of his gravitator. Lancet. 1828; ii, 3210-4.
2. Braun A.A.L., DebenhamM.W. Autotransfusionuse of blood from haemothorax.
JAMA. 1931; 96, 1253.
3. Clark T.W. The birth of transfusion. J of the History of Medicine.
1949; 4, 337-8.
4. Coombs R.R.A., Mourant A.E., Race R.R. A new test for the detection
of week and "incomplete" Rh agglutinin’ s. Brit J of Experimental
Pathology. 1945; 26, 255-66.
5. Coombs R.R.A., Mourant A.E., Race R.R. In-vivo isosesitisation
of red cells in babies with haemolitic disease. Lancet. 1946; I, 264-6.
6. Davis L.E., Cushing H. Experiences with blood replacement during
or after major intracranial operations. Surg Gynecol Obstet. 1025;
40, 310.
7. Decastello A., Sturli A. Ueber die Iso-agglutine im Serum gesunder
und kranker Menschen. Muenschener Medizinische Wochenschrift. 1902;
49, 1090-5.
8. Dyer R.H. Intra-operative autotransfusion. A preliminary report
and a new method. Am J Surg. 1966; 112, 874.
9. Farrar I.K. Autotransfusion-blood retransfusion in gynecology.
Surg Gynecol Obstet. 1923; 36, 454.
10. Giangrande P.L.F. The history of blood transfusion. British Journal
of Haematology. 2000; 110, 758-67.
11. Griswold R.A., Ortner A.B. The use of autotransfusion in surgery
of the serous cavities. Surg Gynecol Obstet. 1943; 77, 167.
12. Hicks J.B. On transfusion and a new mode of management. Brit Medical
Journal. 1868; 2, 151.
13. Hirzsfeld É., Hirzsfeld H. Serological differences between the
blood of different races. The result of researches on the Macedonian
front 1919. Lancet. 1919; ii, 675-9.
14. Keynes G. Tercentenary of blood transfusion. British Medical journal.
iv, 410-11.
15. Klebanoff G. Early experience with a disposable unit for intra-operative
salvage and reinfusion of blood loss intraoperative autotransfusion.
Am J Surg. 1970; 120, 351.
16. Landsteiner K.S., Wiener A.S. An agglutinable factor in human
blood recognized by immune sera for Rhesus blood. Proceedings of the
Society for Experimental Biology and Medicine. 1940; 43, 223.
17. Landsteiner K. On agglutination of normal blood (Translation of
article originally published in 1901: Ueber Agglutinationserscheinungen
normalen menschlichen Blutes. Wiener Klinische Wochenschrift. 1901;
14, 1132-4. Transfusion 1961; 1, 5-8.
18. Levine P., Stetson R.E. An unusual case of intragroup agglutination.
Journal of the American Medical Association. 1939; 113, 126-7.
19. Levine P. A review of Landstener’ s contributions to human blood
groups. Tranfusion. 1961; 1, 45-52.
20. Lewinsohn R. Blood transfusion by the citrate method. Surgical
Gynecology and Obstetrics. 1915; 21, 37-47.
21. Lockwood C.D. Surgical treatment of Banti’s disease. Surg Gynecol
Obstetr. 1917; 25, 188.
22. Noon G.P., Solis R.T., Natelson E.A. A simple method of intraoperative
autotransfusion. Surg Gynecol Obstet. 1976; 143, 65.
23. Papadopoulos G. Chapter 18 "The history of tranfusion".
In the book: "The development of Anesthesiology", Papadopoulos
G. University Studio Press Thessaloniki. 1999 pp 119 – 123.
24. Stehling L.C., Zauder H.L., Rogers W. Intraoperative autotransfusion.
Anesthesiology. 1975; 43, 337.
25. Symbas P.N. Extraoperative autotransfusion from hemothorax. Surgery.
1078; 84, 722.
26. Watson C.M., Watson J.R. Autotransfusion. Review of the literature
with report of two additional cases. Am J Surg. 1936; 33, 232.
27. Wiener A.S. Genetic theory of the Rh blood types. Proceedings
of the Society for Experimental Biology of New York. 1943; 54, 316-9.
28. Wilson J.D., Utz D.C., Taswell H.F. Autotransfusion during transuretratrhal
resection of the prostata: Technique and preliminary clinical evaluation.
Mayo Clin Proc. 1969; 44, 374
Tefa
Louiza
70 G. Seferi Street
45445 Ioannina